New Times,
New Thinking.

  1. Politics
7 June 2012

Have the Tories won a jubilee poll bounce?

Labour's lead is down to nine points in the latest poll.

By George Eaton

There’s been much talk about whether the Conservatives will enjoy a “Jubilee bounce” in the polls, so it’s worth noting that Labour’s lead is down to nine points in the latest YouGov poll, having previously stood at an average of 12. The hope among the Tories is that the extended weekend will have left most voters feeling more content with the state of the nation.

A nine-point lead, of course, is still large enough for Labour to win a substantial majority even after the coalition’s proposed boundary changes have been implemented. Indeed, as I’ve noted before, the biggest obstacle to a Tory majority at the next election is that Cameron’s party will need a lead of seven points on a uniform swing to win a majority (compared to one of 11 points at present), while Labour will need a lead of just four.

We’ll find out tonight whether the YouGov poll is indicative of a modest Conservative recovery or simply an outlier.

Update: Labour’s lead remains at nine in tonight’s YouGov poll. It looks like the Tories are enjoying a jubilee poll bounce.

 

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines